C17orf78 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-60078
Key Product Details
Species Reactivity
Validated:
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.5 mg/ml
Product Summary for C17orf78 Antibody
Immunogen
Synthetic peptides corresponding to C17ORF78 The peptide sequence was selected from the middle region of C17ORF78.
Peptide sequence LGARKLCQCQWLWRWQKKGGQPPGTAESKPDSQPQKVGQDAANSSNPKKA. The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.
Scientific Data Images for C17orf78 Antibody
Western Blot: C17orf78 Antibody [NBP1-60078]
Western Blot: C17orf78 Antibody [NBP1-60078] - Titration: 0.2-1 ug/ml, Positive Control: Jurkat cell lysate.Applications for C17orf78 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: C17orf78
Alternate Names
chromosome 17 open reading frame 78, FLJ39647, hypothetical protein LOC284099, MGC34759
Gene Symbol
C17ORF78
UniProt
Additional C17orf78 Products
Product Documents for C17orf78 Antibody
Product Specific Notices for C17orf78 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...